Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Polypeptides of anti-measles virus and human immunodeficiency virus and use

A technology of immunodeficiency virus and measles virus, which is applied in the field of anti-measles virus and human immunodeficiency virus anti-virus polypeptide of East Asian scorpion, and the field of polypeptide with high-efficiency anti-virus function, which can solve the instability and preventive effect of its own genetic material Reduce the problem of easy mutation and other problems, and achieve the effect of good water solubility, good inhibitory effect and no side effects

Inactive Publication Date: 2008-10-15
WUHAN UNIV
View PDF0 Cites 10 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, some viruses, such as influenza and HIV, have unstable genetic material and are prone to mutations, so that the preventive effect of previous vaccines against this new mutant virus is reduced or completely ineffective.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polypeptides of anti-measles virus and human immunodeficiency virus and use
  • Polypeptides of anti-measles virus and human immunodeficiency virus and use
  • Polypeptides of anti-measles virus and human immunodeficiency virus and use

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0025]Example 1: Preparation of a scorpion venom antiviral polypeptide. Proceed as follows:

[0026] A: Extraction of total RNA from scorpion venom glands (Trizol LS one-step method: Trizol LS was purchased from Invitrogen, USA)

[0027] ① Grind 500mg of scorpion glands into fine powder in liquid nitrogen, add 10ml Trizol LS to mix, and place at room temperature (20-25°C, the same below) for 5 minutes; Minutes, centrifuge at 12,000g for 15 minutes at 4°C; ③Add 1 volume of isopropanol to the water phase, place at room temperature for 10 minutes, and centrifuge at 12,000g for 10 minutes at 4°C to obtain RNA precipitation; ④Wash the precipitate with 5ml of 75% ethanol, and centrifuge at 7,500g for 5 minutes ; ⑤ After the RNA precipitate was dried, it was dissolved in DEPC (diethypyrocarbonate, diethyl pyrocarbonate)-treated sterilized water, and kept at 55-60°C for 10 minutes to completely dissolve the RNA. The whole process was carried out according to the method recommended b...

Embodiment 2

[0075] Example 2: Chemical synthesis of scorpion venom antiviral polypeptide AVP-W1

[0076] A polypeptide AVP-W1 consisting of 13 amino acids was isolated from the venom gland of the East Asian scorpion and was amidated. A high-purity AVP-W1 polypeptide: FVAGVASLVRIKF-NH2 was obtained by solid-phase chemical synthesis.

Embodiment 3

[0077] Example 3: Inhibition of Measles Virus by Antiviral Polypeptide AVP-W1 Drugs

[0078] Material:

[0079] A: Culture of Vero E6 cells

[0080] The African green monkey kidney epithelial cell line (VeroE6) was purchased from China Center for Type Culture Collection.

[0081] Medium: 10% (passage medium) or 2% (maintenance medium) calf serum (FCS, GIBCO-BRL), 56 ° C, 30 minutes heat sterilization; 2mM / mL L-glutamate; 100U / mL Penicillin and 100 μg / mL streptomycin. Culture conditions are: 37°C, 5% CO 2 Incubator cultivation.

[0082] B: virus strain

[0083] The Edmonston measles virus used in this study came from the Wuhan Institute of Virology, Chinese Academy of Sciences (purchased from the American Type Culture Collection).

[0084] Specific operation method:

[0085] Monolayer Vero E6 cells were inoculated in a 96-well plate, 10 per well 4 For cells, add resistant medium to allow the cells to grow and adhere to the wall. The virus was added to the maintenance m...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses scorpion toxin antiviral polypeptide and a use of the same. Scorpion toxin antivirotic polypeptide (AVP-W1) is obtained through a molecular biological and chemical synthesis method, and then the antiviral activity of the AVP-W1 on measles virus (MeV) and human immunodeficiency virus (HIV) is measured through adopting an antibody neutralization method; moreover, the measurement shows that the AVP-W1 can effectively inhibit virus infection at a low concentration. The AVP-W1 has a tremendous prospect in making applied medicine which can cure or prevent a disease caused by virus. Moreover, the antiviral peptide of the invention has high activity on MeV and HIV and a simple method, and can be developed as antiviral medicine.

Description

technical field [0001] The invention belongs to the field of biotechnology, and more specifically relates to a polypeptide with high-efficiency antiviral function. Specifically, the present invention relates to the use of an antiviral polypeptide of the scorpion scorpion in anti-measles virus (MeV) and human immunodeficiency virus (HIV). Background technique [0002] Virus infection is a disease that seriously endangers human health, and this problem has plagued human beings for many years. As early as 412 BC in ancient Greece, Hippocrates had already described influenza-like diseases; from 1742 to 1743, influenza caused by influenza viruses had affected 90% of Eastern Europeans; from 1889 to 1894 The "Russian flu" that swept through Western Europe in 1950 had a wide range of morbidity and a high mortality rate; in 1918, a deadly flu swept the world, causing 20 to 50 million deaths; the "Asian flu" in 1957 and the "Hong Kong flu" in 1968 According to statistics in the Unit...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K7/08C12N15/12A61K38/10A61P31/14A61P31/18
Inventor 李文鑫曹志贱戴潮鄢慧民赵震环
Owner WUHAN UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com